These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 25944340

  • 1. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.
    Blomberg M, Dehlendorff C, Sand C, Kjaer SK.
    Clin Infect Dis; 2015 Sep 01; 61(5):676-82. PubMed ID: 25944340
    [Abstract] [Full Text] [Related]

  • 2. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.
    Blomberg M, Dehlendorff C, Munk C, Kjaer SK.
    Clin Infect Dis; 2013 Oct 01; 57(7):929-34. PubMed ID: 23804192
    [Abstract] [Full Text] [Related]

  • 3. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L.
    JAMA; 2014 Feb 12; 311(6):597-603. PubMed ID: 24519299
    [Abstract] [Full Text] [Related]

  • 4. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
    Baandrup L, Dehlendorff C, Kjaer SK.
    Clin Infect Dis; 2021 Nov 02; 73(9):e3220-e3226. PubMed ID: 33048118
    [Abstract] [Full Text] [Related]

  • 5. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
    Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK.
    Sex Transm Dis; 2013 Feb 02; 40(2):130-5. PubMed ID: 23324976
    [Abstract] [Full Text] [Related]

  • 6. Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.
    Lamb F, Herweijer E, Ploner A, Uhnoo I, Sundström K, Sparén P, Arnheim-Dahlström L.
    BMJ Open; 2017 Jun 08; 7(6):e015021. PubMed ID: 28600369
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    Dominiak-Felden G, Gobbo C, Simondon F.
    PLoS One; 2015 Jun 08; 10(7):e0132404. PubMed ID: 26147096
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
    Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L.
    J Natl Cancer Inst; 2013 Apr 03; 105(7):469-74. PubMed ID: 23486550
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E, López-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J.
    Vaccine; 2017 Jun 05; 35(25):3342-3346. PubMed ID: 28499554
    [Abstract] [Full Text] [Related]

  • 11. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
    Orumaa M, Kjaer SK, Dehlendorff C, Munk C, Olsen AO, Hansen BT, Campbell S, Nygård M.
    Vaccine; 2020 Feb 05; 38(6):1345-1351. PubMed ID: 31917039
    [Abstract] [Full Text] [Related]

  • 12. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
    Perkins RB, Lin M, Wallington SF, Hanchate A.
    Sex Transm Dis; 2017 Jun 05; 44(6):365-370. PubMed ID: 28499288
    [Abstract] [Full Text] [Related]

  • 13. Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study.
    Cocchio S, Baldovin T, Bertoncello C, Buja A, Furlan P, Saia M, Baldo V.
    BMC Infect Dis; 2017 Apr 05; 17(1):249. PubMed ID: 28381294
    [Abstract] [Full Text] [Related]

  • 14. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB, Legler A, Hanchate A.
    Sex Transm Dis; 2015 Dec 05; 42(12):665-8. PubMed ID: 26562694
    [Abstract] [Full Text] [Related]

  • 15. Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States.
    Hariri S, Schuler MS, Naleway AL, Daley MF, Weinmann S, Crane B, Newcomer SR, Tolsma D, Markowitz LE.
    Am J Epidemiol; 2018 Feb 01; 187(2):298-305. PubMed ID: 28641366
    [Abstract] [Full Text] [Related]

  • 16. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years.
    Petráš M, Adámková V.
    Vaccine; 2015 Nov 17; 33(46):6264-7. PubMed ID: 26431981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.
    Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF.
    J Infect Dis; 2012 Sep 15; 206(6):860-6. PubMed ID: 22815381
    [Abstract] [Full Text] [Related]

  • 19. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK.
    Sex Transm Infect; 2015 May 15; 91(3):214-9. PubMed ID: 25305210
    [Abstract] [Full Text] [Related]

  • 20. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
    Mariani L, Vici P, Suligoi B, Checcucci-Lisi G, Drury R.
    Adv Ther; 2015 Jan 15; 32(1):10-30. PubMed ID: 25620536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.